Article
Chromothripsis in myeloid malignancies.
Annals of hematology - 1 Oct 2024
Chen Chien-Yuan
Abstract excerpt
Chromothripsis refers to massive genomic rearrangements developed during a catastrophic event. In total acute myeloid leukemia (AML), the incidence of chromothripsis ranges from 0 to 6.6%, in cases of complex karyotype AML, the incidence of chromothripsis ranges from 27.3 to 100%, whereas in cases of AML with TP53 mutations, the incidence ranges from 11.1 to 90%. For other types of malignancies, the incidence of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
